These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14586273)

  • 1. The use of corticosteroids versus other treatments for Graves' ophthalmopathy: a quantitative evaluation.
    Abalkhail S; Doi SA; Al-Shoumer KA
    Med Sci Monit; 2003 Nov; 9(11):CR477-83. PubMed ID: 14586273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence.
    Wei RL; Cheng JW; Cai JP
    Ophthalmologica; 2008; 222(1):27-31. PubMed ID: 18097177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
    Brauer VF; Scholz GH
    Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HLA antigen BW35 with severe Graves' ophthalmopathy.
    Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
    Bednarek J; Wysocki H; Sowiński J
    Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience of radiation therapy for Graves' ophthalmopathy.
    Takahashi T; Mitsuhashi N; Nagashima H; Sakurai H; Murata O; Ishizeki K; Shimaya S; Hayakawa K; Niibe H
    Radiat Med; 1996; 14(6):343-7. PubMed ID: 9132818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study.
    Wakelkamp IM; Tan H; Saeed P; Schlingemann RO; Verbraak FD; Blank LE; Prummel MF; Wiersinga WM
    Ophthalmology; 2004 Aug; 111(8):1557-62. PubMed ID: 15288988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioiodine therapy for Graves' disease: problems and new developments].
    Reiners C
    Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():55-62. PubMed ID: 15255314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD40 and its ligand CD154 in patients with Graves' ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy.
    Myśliwiec J; Waligórski D; Nikołajuk A; Górska M
    Adv Med Sci; 2007; 52():104-8. PubMed ID: 18217399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbital irradiation in the treatment of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Panicucci M; Bogazzi F; Pinchera A
    Bull Soc Belge Ophtalmol; 1988; 226():71-83. PubMed ID: 3151769
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.
    Zoumalan CI; Cockerham KP; Turbin RE; Volpe NJ; Kazim M; Douglas RS; Feldon SE
    J Neuroophthalmol; 2007 Sep; 27(3):205-14. PubMed ID: 17895822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.
    Bartalena L; Marcocci C; Chiovato L; Laddaga M; Lepri G; Andreani D; Cavallacci G; Baschieri L; Pinchera A
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1139-44. PubMed ID: 6341388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids in the medical management of Graves' ophthalmopathy.
    Hart RH; Perros P
    Minerva Endocrinol; 2003 Sep; 28(3):223-31. PubMed ID: 14605604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Graves' ophthalmopathy: diagnosis and highlights on etiopathogenesis and treatment].
    Kamoun M; Abid H; Lamine F; Slimane H; Haddad A
    Tunis Med; 2003 Mar; 81(3):149-55. PubMed ID: 12793063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis.
    Stiebel-Kalish H; Robenshtok E; Hasanreisoglu M; Ezrachi D; Shimon I; Leibovici L
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2708-16. PubMed ID: 19491222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease.
    Bufalo NE; Santos RB; Cury AN; Andrade RA; Morari J; Morari EC; Leite JL; Monte O; Romaldini JH; Ward LS
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):982-7. PubMed ID: 17980001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observational study of intravenous versus oral corticosteroids for acute asthma: an example of confounding by severity.
    Clark S; Costantino T; Rudnitsky G; Camargo CA
    Acad Emerg Med; 2005 May; 12(5):439-45. PubMed ID: 15860696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
    Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
    Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Graves' ophthalmopathy with irradiation].
    Slampa P; Spurný V; Seneklová Z; Krákorová D
    Vnitr Lek; 1998 Aug; 44(8):461-3. PubMed ID: 10358449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.